A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples